Key Drivers
- Strong Cash Flow
- Heavy Debt Load
- Negative Equity
AIAI Summary
BHC is a leveraged cash-flow-repair investment, not a conventional cheap healthcare turnaround: operational gains matter only if sustained free cash flow materially reduces its ~$19B net debt, while thin interest coverage leaves equity highly vulnerable to any execution or refinancing setback.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Cash Flow
- •Heavy Debt Load
- •Negative Equity
BHC's improving cash flow and margins are outweighed by extreme leverage, negative equity, and intangible-heavy assets, making the low sales valuation high-risk rather than clearly attractive.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Tentative support
- •Key breakout
BHC fell about 17% over the last month, with $5.65–$5.70 support holding tentatively, but a break below it risks further losses while a move above $6.16 would improve momentum.
Sharp reversal from $6.93 to $5.65 signals sustained selling pressure
Sentiment & News
Key News Insights:
- •Earnings Upgrade
- •Eye-Care Growth
- •Pipeline Progress
Bausch Health shows improving momentum from earnings upgrades, eye-care growth, pipeline advances, and global expansion, though deleveraging remains a key risk.
The developments are broadly positive for BHC shares, but balance-sheet pressures may limit upside
Similar Companies in Healthcare
Other companies in the same sector with AI ratings